Dataset Viewer
Auto-converted to Parquet Duplicate
sponsor
stringlengths
3
120
sponsor_type
stringclasses
4 values
total_trials
int64
5
4.52k
active_trials
int64
0
1.31k
completed_trials
int64
0
2.16k
failed_trials
int64
0
619
phase_1_count
int64
0
953
phase_2_count
int64
0
1.8k
phase_3_count
int64
0
729
phase_4_count
int64
0
281
completion_rate
unknown
avg_duration_days
unknown
first_trial_date
date32
latest_trial_date
date32
primary_therapeutic_focus
stringclasses
20 values
therapeutic_area_count
int64
0
20
Shannon E. Sauer-Zavala
other
5
1
4
0
0
0
0
0
"1.000"
"742"
2019-10-28
2024-10-16
psychiatry
1
Moroccan Society of Surgery
other
12
0
8
1
0
0
0
0
"0.889"
"982"
2005-01-01
2022-11-01
oncology
4
Kyowa Kirin Co., Ltd.
industry
157
13
128
15
50
45
51
5
"0.895"
"516"
2015-09-28
2025-05-02
oncology
14
Sanofi
other
1,511
160
1,165
183
221
345
566
281
"0.864"
"722"
2003-12-30
2026-10-01
metabolic
20
Institut Rafael
other
5
1
4
0
0
0
0
0
"1.000"
"76"
2023-06-01
2024-04-19
hematology
2
California Pacific Medical Center Research Institute
academic
39
5
26
2
2
12
0
4
"0.929"
"778"
2016-11-17
2024-04-22
oncology
9
Zenas BioPharma (USA), LLC
industry
10
7
3
0
4
2
4
0
"1.000"
"263"
2022-10-16
2024-09-17
healthy_volunteers
4
Steward St. Elizabeth's Medical Center of Boston, Inc.
industry
23
2
12
8
1
2
1
3
"0.600"
"566"
2012-02-12
2023-06-01
cardiovascular
8
University School of Physical Education, Krakow, Poland
academic
18
6
9
0
0
0
0
0
"1.000"
"786"
2013-06-01
2025-09-01
respiratory
7
Hospital Clinic of Barcelona
academic
311
45
166
14
4
14
24
51
"0.922"
"619"
2008-01-02
2026-01-31
cardiovascular
18
Roxall Medicina España S.A
other
15
0
14
0
7
4
0
0
"1.000"
"881"
2016-11-23
2019-05-23
ophthalmology
2
Adaptimmune
other
16
4
4
8
8
6
0
0
"0.333"
"1428"
2011-06-01
2021-09-15
oncology
1
Ansun Biopharma, Inc.
industry
10
1
7
1
3
5
2
0
"0.875"
null
2009-05-18
2020-07-25
infectious_disease
3
Qian Chu
other
6
5
1
0
0
3
0
0
"1.000"
"1100"
2019-07-12
2025-12-01
oncology
1
Riyadh Elm University
academic
22
6
7
0
1
0
0
6
"1.000"
"158"
2019-11-01
2026-03-15
musculoskeletal
4
Otolith Labs
other
11
1
5
4
0
0
0
0
"0.556"
"507"
2018-10-01
2024-08-27
neurology
2
Universität des Saarlandes
other
63
14
41
1
2
5
6
2
"0.976"
"791"
2001-01-01
2025-10-30
cardiovascular
14
Panacea Biotec Ltd
other
10
0
9
0
1
1
0
0
"1.000"
null
null
null
healthy_volunteers
3
University Hospital of Mont-Godinne
academic
22
6
6
6
0
1
2
1
"0.500"
"368"
2017-04-01
2023-12-11
cardiovascular
4
Children's Hospitals and Clinics of Minnesota
academic
48
5
23
8
0
5
2
3
"0.742"
"1707"
2009-12-22
2024-02-22
respiratory
13
Johnson & Johnson Medical, China
other
9
0
5
4
0
0
1
0
"0.556"
"424"
2010-03-25
2017-06-12
cardiovascular
3
Lisette Nixon
other
8
1
4
0
0
4
3
0
"1.000"
"1537"
2012-01-26
2016-11-04
oncology
1
Changchun BCHT Biotechnology Co.
industry
16
8
2
0
6
3
4
2
"1.000"
"454"
2020-04-20
2026-02-07
infectious_disease
1
Medtronic Cardiac Rhythm and Heart Failure
other
261
9
219
32
6
3
5
29
"0.873"
"840"
1999-06-09
2025-07-09
cardiovascular
4
Shanghai HEP Pharmaceutical Co., Ltd.
industry
8
2
5
1
2
5
1
0
"0.833"
"551"
2021-06-18
2024-12-11
infectious_disease
1
National Center for Tumor Diseases, Heidelberg
government
12
0
6
5
2
7
1
0
"0.545"
"1881"
2016-05-01
2018-10-25
oncology
2
ZIWIG
other
7
6
0
0
0
0
0
0
null
null
2021-12-15
2025-02-01
reproductive
3
St George's Healthcare NHS Trust
academic
5
0
1
0
0
0
0
0
"1.000"
null
null
null
cardiovascular
4
Sanofi Pasteur, a Sanofi Company
other
374
18
340
16
25
104
142
62
"0.955"
"604"
2006-07-01
2025-10-23
infectious_disease
5
Assembly Biosciences
industry
21
2
13
6
13
8
0
0
"0.684"
"248"
2017-06-15
2025-01-31
infectious_disease
1
Egetis Therapeutics
industry
7
0
5
2
2
3
2
0
"0.714"
"234"
2017-06-08
2019-01-07
neurology
3
Viatris Innovation GmbH
industry
23
6
16
1
14
4
5
0
"0.941"
"329"
2015-04-28
2026-02-09
healthy_volunteers
4
Ankara City Hospital Bilkent
academic
361
90
220
1
1
1
0
10
"0.995"
"268"
2012-01-01
2026-03-20
musculoskeletal
20
The University Clinic of Pulmonary and Allergic Diseases Golnik
academic
16
1
9
1
1
0
1
0
"0.900"
"524"
2016-01-01
2024-03-01
respiratory
5
Claude Bernard University
academic
31
4
26
0
0
0
1
1
"1.000"
"187"
2015-04-01
2025-04-01
psychiatry
6
University of Otago
academic
13
2
11
0
0
0
1
1
"1.000"
"434"
2021-06-02
2025-06-12
psychiatry
5
TearScience, Inc.
industry
6
0
6
0
0
0
1
0
"1.000"
null
null
null
ophthalmology
1
Chulalongkorn University
academic
296
53
165
5
16
20
25
38
"0.971"
"425"
2010-07-01
2026-03-01
infectious_disease
18
Batman Training and Research Hospital
academic
8
0
8
0
0
0
0
0
"1.000"
"1275"
2002-04-12
2022-04-12
healthy_volunteers
3
Universidade do Sul de Santa Catarina
other
5
1
4
0
0
1
0
1
"1.000"
null
2023-03-01
2023-03-01
cardiovascular
5
Universita di Verona
other
119
23
49
7
5
3
2
16
"0.875"
"546"
2012-09-27
2026-02-01
cardiovascular
12
Guangdong Provincial People's Hospital
academic
216
82
41
4
5
37
15
18
"0.911"
"1335"
2000-01-01
2026-02-01
oncology
13
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
other
137
15
68
12
0
14
10
14
"0.850"
"845"
1993-01-01
2026-02-01
metabolic
14
Hanan Jafar
other
6
0
1
0
2
4
0
0
"1.000"
"698"
2013-11-15
2018-02-03
metabolic
2
Colorado School of Public Health
academic
7
2
4
0
0
0
0
0
"1.000"
"669"
2017-04-01
2022-11-02
psychiatry
3
Società Italiana Talassemie ed Emoglobinopatie
other
8
3
5
0
0
0
0
0
"1.000"
"275"
2015-03-01
2022-02-01
hematology
2
National Center for Gastroentestinal and Liver Disease
government
6
0
6
0
0
0
0
0
"1.000"
"379"
2012-06-01
2022-06-01
hematology
3
Emory University
academic
1,372
291
822
248
140
227
59
151
"0.768"
"913"
2006-10-06
2026-06-01
oncology
20
Sunstar Americas
other
10
0
8
2
0
0
1
0
"0.800"
"453"
2016-08-02
2021-06-30
gastroenterology
2
Sino Medical Sciences Technology Inc.
industry
13
4
7
2
0
0
1
1
"0.778"
"493"
2015-04-27
2024-07-09
cardiovascular
1
University of Malta
academic
12
2
7
0
0
0
0
0
"1.000"
"610"
2014-03-01
2024-09-01
respiratory
6
Fundacao Champalimaud
other
14
8
2
0
1
2
0
0
"1.000"
"761"
2011-12-01
2024-11-07
oncology
2
HKGepitherapeutics
industry
5
0
1
4
0
0
0
0
"0.200"
"651"
2018-06-01
2019-12-01
oncology
2
Fondation Ophtalmologique Adolphe de Rothschild
other
312
82
167
61
1
4
11
7
"0.732"
"971"
2005-01-01
2026-09-15
neurology
13
Xintian Pharmaceutical
industry
6
2
4
0
0
0
0
6
"1.000"
"1013"
2016-10-02
2024-07-30
urology
2
Zydolab - Institute of Cytology and Immune Cytochemistry
academic
10
1
9
0
0
0
0
0
"1.000"
"399"
2017-02-01
2024-01-02
reproductive
2
JW Pharmaceutical
industry
72
7
59
2
25
7
16
15
"0.967"
"370"
2012-04-02
2026-01-26
healthy_volunteers
9
California Retina Consultants
other
10
0
9
0
2
4
0
4
"1.000"
"711"
2015-03-13
2019-07-16
ophthalmology
1
Winston Laboratories
industry
10
1
7
2
2
3
5
0
"0.778"
null
null
null
healthy_volunteers
4
Fytexia
other
11
1
10
0
0
0
0
0
"1.000"
"273"
2018-02-23
2025-04-30
metabolic
3
Norwegian Center for Violence and Traumatic Stress Studies
other
13
3
6
0
0
0
0
0
"1.000"
"1545"
2012-01-01
2024-09-13
psychiatry
3
Sarfez Pharmaceuticals, Inc.
industry
11
6
3
2
3
2
4
2
"0.600"
"187"
2017-06-19
2025-12-01
cardiovascular
2
VaxInnate Corporation
other
12
0
9
0
8
4
0
0
"1.000"
null
null
null
infectious_disease
1
Oslo University Hospital
academic
808
200
419
45
16
91
40
66
"0.903"
"1022"
1972-01-15
2026-04-01
cardiovascular
20
Emilio Bouza
other
5
0
3
0
0
0
0
0
"1.000"
null
2019-11-01
2019-12-01
infectious_disease
1
Hospital Universitario Doctor Peset
academic
6
1
1
0
0
1
0
0
"1.000"
"474"
2017-03-09
2023-02-08
gastroenterology
2
Integrative Skin Science and Research
other
33
5
8
0
0
0
0
0
"1.000"
"219"
2019-09-10
2024-07-22
dermatology
3
The Geneva Foundation
academic
10
6
2
2
0
0
0
0
"0.500"
"943"
2015-08-25
2026-01-01
infectious_disease
3
Gemin X
other
12
0
10
2
3
9
0
0
"0.833"
null
null
null
oncology
2
King Fahad Armed Forces Hospital
academic
5
2
3
0
0
1
0
0
"1.000"
"578"
2014-04-01
2025-01-06
neurology
2
NantCell, Inc.
industry
13
0
9
4
1
11
1
0
"0.692"
"1470"
2008-03-27
2017-06-26
oncology
1
Lohmann & Rauscher
other
8
5
3
0
0
0
0
0
"1.000"
"614"
2018-01-24
2025-09-23
cardiovascular
3
Summa Health System
other
20
0
16
4
1
2
0
2
"0.800"
"847"
2005-10-17
2022-12-07
cardiovascular
7
Healeon Medical Inc
other
9
1
0
8
2
4
0
0
"0.000"
null
2016-08-14
2020-01-10
immunology
3
University of Southern California
academic
766
163
375
172
76
125
17
34
"0.686"
"1037"
1994-01-01
2027-07-01
oncology
20
Hellenic Mediterranean University
academic
6
3
3
0
0
0
0
0
"1.000"
"365"
2022-12-15
2024-09-01
cardiovascular
4
Justin Fraser
other
5
1
3
1
3
0
0
0
"0.750"
"867"
2013-02-01
2017-10-11
cardiovascular
1
Third Wave Therapeutics
industry
5
0
4
1
0
0
0
0
"0.800"
"212"
2020-07-15
2025-01-09
psychiatry
1
Marinus Pharmaceuticals
industry
22
0
16
5
0
14
7
0
"0.762"
"726"
2015-11-06
2023-04-01
neurology
3
University Hospital, Umeå
academic
6
1
4
0
0
0
0
0
"1.000"
null
2019-12-10
2019-12-10
gastroenterology
5
Alung Technologies
other
5
0
2
2
0
0
1
0
"0.500"
null
2018-02-18
2018-02-18
respiratory
1
PowderMed
other
6
0
6
0
6
0
0
0
"1.000"
null
null
null
infectious_disease
1
National Institute of Nutrition and Seafood Research, Norway
academic
6
0
5
1
0
0
0
0
"0.833"
null
null
null
neurology
4
Helios Albert-Schweitzer-Klinik Northeim
other
6
0
2
0
0
0
0
0
"1.000"
null
2018-03-27
2018-03-27
gastroenterology
2
Anne Chang
other
5
0
4
1
1
3
0
0
"0.800"
"658"
2016-02-01
2017-06-21
oncology
2
Fayoum University
academic
125
39
64
1
6
7
4
8
"0.985"
"232"
2017-01-01
2026-07-01
musculoskeletal
17
Nicolaus Copernicus University
academic
19
2
10
1
0
1
2
0
"0.909"
"1333"
2010-01-15
2024-09-24
cardiovascular
8
ZOLL Circulation, Inc., USA
industry
10
0
9
0
0
0
0
0
"1.000"
"1150"
2017-04-14
2019-05-23
cardiovascular
2
Alentis Therapeutics AG
industry
5
3
1
1
1
4
0
0
"0.500"
"578"
2023-04-01
2025-08-26
oncology
2
Elisabethinen Hospital
academic
5
1
0
1
0
2
1
0
"0.000"
null
2021-04-01
2024-01-11
oncology
2
Immatics US, Inc.
industry
7
3
4
0
4
1
1
0
"1.000"
"1407"
2017-06-30
2025-07-25
oncology
1
Gyroscope Therapeutics Limited
industry
5
1
0
4
0
4
0
0
"0.000"
null
2018-12-17
2022-07-12
ophthalmology
1
San Camillo Hospital, Rome
academic
5
0
2
0
0
0
0
1
"1.000"
"832"
2018-07-01
2023-02-15
cardiovascular
3
Centre Hospitalier le Mans
academic
41
13
8
2
0
0
0
1
"0.800"
"1435"
2000-01-01
2026-01-01
infectious_disease
11
Bjorn H. Ebdrup
other
5
3
1
1
1
1
1
0
"0.500"
null
2021-05-26
2025-01-01
psychiatry
2
Lumos Pharma
industry
6
4
2
0
0
4
2
0
"1.000"
"1206"
2020-12-31
2023-08-01
endocrine
1
Life Molecular Imaging SA
other
14
0
11
3
10
3
1
0
"0.786"
null
2021-06-07
2021-06-07
neurology
3
Fondazione IRCCS Policlinico San Matteo di Pavia
academic
220
104
77
14
0
24
15
7
"0.846"
"742"
2010-01-01
2026-02-01
oncology
18
Faculdade de Medicina de Valenca
other
6
0
5
0
0
0
0
0
"1.000"
"668"
2023-02-01
2023-02-01
neurology
3
Kaohsiung Medical University Chung-Ho Memorial Hospital
academic
276
38
160
2
2
8
7
38
"0.988"
"813"
2001-01-01
2026-01-12
infectious_disease
18
End of preview. Expand in Data Studio

Clinical Trial Sponsor Analytics

⬇️ This is a 10% sample. Get the full dataset (10,200+ sponsors) on Gumroad →

10,200+ clinical trial sponsors profiled with trial volume, completion rates, phase distribution, therapeutic focus, and pipeline activity. Built for competitive intelligence, due diligence, and portfolio analysis.

Why This Dataset Exists

Answering questions like "What's Pfizer's completion rate in oncology?" or "Which biotech sponsors have the most active Phase 3 trials?" currently requires querying ClinicalTrials.gov, cleaning sponsor names, classifying therapeutic areas, and computing aggregates manually. This dataset pre-computes it all into one row per sponsor.

Schema

Column Type Description
sponsor str Sponsor organization name
sponsor_type str industry / academic / government / other
total_trials int Total trials sponsored
active_trials int Currently recruiting or active trials
completed_trials int Successfully completed trials
failed_trials int Terminated, withdrawn, or suspended trials
phase_1_count int Phase 1 trials
phase_2_count int Phase 2 trials
phase_3_count int Phase 3 trials
phase_4_count int Phase 4 / post-market trials
completion_rate float Completed / (Completed + Failed), 0-1
avg_duration_days int Average trial duration (completed trials)
first_trial_date date Earliest trial start date
latest_trial_date date Most recent trial start date
primary_therapeutic_focus str Most common therapeutic area for this sponsor
therapeutic_area_count int Number of distinct therapeutic areas

Key Stats

  • 10,220 sponsors with 5+ trials
  • 2,630 industry sponsors, 3,739 academic, 183 government
  • Average completion rate: 87% across all sponsors
  • AI-classified therapeutic areas linked from 2,500+ condition mappings

Top Sponsors by Trial Volume

Sponsor Trials Completion Rate Focus
Assiut University 4,524 97% Cardiovascular
Cairo University 4,365 99% Musculoskeletal
GlaxoSmithKline 3,583 90% Infectious Disease
National Cancer Institute 3,524 79% Oncology
AstraZeneca 3,394 90% Oncology
Pfizer 3,238 82% Healthy Volunteers
Mayo Clinic 3,160 80% Oncology
M.D. Anderson Cancer Center 2,963 66% Oncology
Novartis Pharmaceuticals 2,601 80% Oncology

Use Cases

  • Competitive intelligence: Compare pipeline size and completion rates across sponsors in a therapeutic area
  • Due diligence: Evaluate a biotech's clinical track record before investment or partnership
  • Market landscape: Which sponsors are most active in a given disease area?
  • Benchmarking: How does your organization's trial completion rate compare to peers?

Sample

This is a 10% random sample. The full dataset (10,220 sponsors) is available for purchase.

Sources

Trial data from ClinicalTrials.gov API. Therapeutic area classifications generated using Claude AI (Anthropic) and rule-based keyword mapping. Sponsor type classified via regex pattern matching.

License

Derived from U.S. government public data. AI classifications provided as-is.

Purchase

For the full dataset: https://mandiasdata.gumroad.com/l/clinical-trials-sponsor-analytics

Downloads last month
22